News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Merck & Co., Inc., Novartis Corporation Blood Cancer Drugs May Shrink Child Tumors, Study Finds
March 30, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- A family of blood cancer drugs made by Merck & Co. and Novartis AG (NOVN) may help treat a rare and incurable disease that causes large tumors to form in the chest, head and neck of children, Harvard researchers report.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Merck & Co.
MORE ON THIS TOPIC
Cardiovascular disease
Ionis’ Tryngolza ‘Game-Changing in Lowering Triglycerides, Cementing Case for FDA Filing
November 10, 2025
·
2 min read
·
Tristan Manalac
Cardiovascular disease
Merck Builds Case for Cholesterol-Lowering Pill With Injectable-Like Efficacy
November 10, 2025
·
2 min read
·
Tristan Manalac
IgA nephropathy
Vera Builds ‘Compelling Profile’ for Atacicept in IgAN, Eyes Q4 Filing
November 7, 2025
·
2 min read
·
Tristan Manalac
Gene therapy
Patient Dies After Receiving Intellia’s CRISPR Gene Therapy Candidate
November 7, 2025
·
2 min read
·
Tristan Manalac